During the past decade, Casa di Cura Igea conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Casa di Cura Igea" #1 collaborator was "Mario Negri Institute for Pharmacological Research" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Casa di Cura Igea" are "Colon Cancer" (1 trials) and "Locally Advanced Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Casa di Cura Igea" in a lesser frequency.

Most popular intervention types in "Casa di Cura Igea" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "FOLFOX (Oxaliplatin, 5Fluorouracil, Lederfolin)" (1 trials), "Gemcitabina, Cisplatino" (1 trials) and "Sorafenib 400 mg po bid, continuously" (1 trials). Other intervention names were less common.

The vast majority of trials in "Casa di Cura Igea" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Casa di Cura Igea". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Casa di Cura Igea, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Casa di Cura Igea, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".